Clinical Trials Directory

Trials / Completed

CompletedNCT05583643

Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment

Syringeable Atorvastatin Loaded Eugenol Enriched PEGylated Cubosomes In-situ Gel for the Intra-pocket Treatment of Periodontitis: Statistical Optimization and Clinical Assessment

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Misr University for Science and Technology · Academic / Other
Sex
All
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

Periodontitis is a destructive chronic inflammatory disease characterized by periodontium damage and pocket formation between the tooth and the gingival margin resulting in ultimate tooth loss. Various topical anti-inflammatory drugs were used to treat inflammation in periodontitis. Introducing atorvastatin as a novel remedy for periodontitis treatment necessitates developing a syringeable modified delivery system capable of targeting inflammation within the periodontal pockets.

Conditions

Interventions

TypeNameDescription
DRUGAtorvastatin CalciumAtorvastatin loaded into nano particles in-situ gel adjunctive to scaling and debridement
DRUGAtorvastatin CalciumAtorvastatin loaded into in-situ gel adjunctive to scaling and debridement
OTHERScaling and debridement onlyScaling and debridement only

Timeline

Start date
2021-12-07
Primary completion
2022-04-15
Completion
2022-06-30
First posted
2022-10-18
Last updated
2022-10-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05583643. Inclusion in this directory is not an endorsement.